Abstract
Background A growing number of people living with HIV (PLHIV) also have non-communicable diseases (NCDs). Shifting the health systems paradigm from vertical, parallel care to an integrated delivery model may facilitate better care-seeking and ultimately improve outcomes for people with a dual burden of HIV and NCDs. We describe the current state of integration of hypertension and diabetes care into HIV treatment in primary healthcare facilities in Malawi, South Africa and Zambia.
Methods We administered structured interviews to HIV treatment providers in 41 primary healthcare facilities across the three countries to evaluate how NCD care is provided to PLHIV accessing antiretroviral therapy (ART). We defined integration as provision of all NCD services to PLHIV in the HIV clinic. The potential degree of integration in HIV clinics ranged from not integrated at all (no NCD services) to fully integrated (all NCD services). We also surveyed a sample of ART clients at the same facilities about their access to integrated HIV and non-HIV care.
Results The degree of integration varied across the facilities and by country. All facilities (n=17) in South Africa reported being fully integrated for HIV care and hypertension and diabetes, and most providers in South Africa identified no barriers to integration. Integration was much less complete in Malawi and Zambia, with most facilities offering hypertension and diabetes screening/diagnosis and support but no treatment or disease monitoring services. Frequently cited barriers to integration in Malawi and Zambia were limited staff knowledge of integrated care provision and facility space constraints. Experience of ART clients experience with integrated services mirrored provider responses. Over 90% of survey participants in South Africa reported HIV and non-HIV visit and medication collection alignment, compared to fewer than half in Malawi and Zambia.
Conclusions The level of integration of hypertension and diabetes care with HIV treatment varies widely across facilities and within districts in Malawi, South Africa, and Zambia, despite each country having national guidelines that promote integration. Interventions to increase integration must take into account differences among facilities at baseline. South Africa’s strategy for integrated chronic disease care has resulted in greater integration than have approaches in neighboring countries.
Competing Interest Statement
PLM holds a position in a government agency that has supervisory authority over some of the healthcare facilities involved in this study. The authors declare that they have no other competing interests.
Clinical Protocols
https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-023-09813-w
https://gatesopenresearch.org/articles/7-119
Funding Statement
Funding for this study was provided by the Bill & Melinda Gates Foundation through INV-031690 to Boston University and INV-037138 to the Wits Health Consortium. The funder had no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was provided by the Boston University Institutional Review Board (Malawi H-41345, South Africa H-41402 and H-42726, Zambia H-41512 and H-42903); the University of Witwatersrand Human Research Ethics Committee (Malawi M210270, South Africa M210241 and M220440, Zambia M210342 and M210342) in South Africa; the Malawi National Health Science Research Committee (21/03/2672); and the ERES-Converge IRB (2021-Mar-012 and 2022-June-007) in Zambia. Verbal consent was obtained from both the facility manager and the ART clinic staff responding to the facility instrument. Written informed consent was obtained for the individual patient surveys.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All facility-level data produced in the present study are contained in the manuscript and supplementary files. Patient-level data are available upon reasonable request to the authors.
